It makes sense and dollars to buy Nutex Health Inc (NUTX) stock

Nutex Health Inc (NASDAQ: NUTX) stock fell -4.89% on Monday to $0.22 against a previous-day closing price of $0.23. With 0.81 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.64 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $0.2385 whereas the lowest price it dropped to was $0.2200. The 52-week range on NUTX shows that it touched its highest point at $2.46 and its lowest point at $0.18 during that stretch. It currently has a 1-year price target of $1.88. Beta for the stock currently stands at 0.61.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NUTX was down-trending over the past week, with a drop of -12.39%, but this was up by 10.11% over a month. Three-month performance dropped to -29.73% while six-month performance fell -56.64%. The stock lost -79.05% in the past year, while it has lost -88.42% so far this year. A look at the trailing 12-month EPS for NUTX yields -0.04 with Next year EPS estimates of -0.01. For the next quarter, that number is -0.01. This implies an EPS growth rate of 96.27% for this year and 40.00% for next year.

Float and Shares Shorts:

At present, 650.22 million NUTX shares are outstanding with a float of 357.78 million shares on hand for trading. On Oct 30, 2023, short shares totaled 2.18 million, which was 0.33% higher than short shares on Sep 28, 2023. In addition to Dr. Thomas T. Vo M.B.A., M.D. as the firm’s Chairman of the Board & CEO, Dr. Warren Hosseinion M.D. serves as its President & Director.

Institutional Ownership:

Other institutions hold 41.70% of NUTX, in contrast to 2.81% held by mutual funds. Shares owned by individuals account for 2.51%. As the largest shareholder in NUTX with 1.87% of the stake, The Vanguard Group, Inc. holds 12,400,374 shares worth 12,400,374. A second-largest stockholder of NUTX, BlackRock Fund Advisors, holds 4,889,734 shares, controlling over 0.74% of the firm’s shares. Geode Capital Management LLC is the third largest shareholder in NUTX, holding 3,141,693 shares or 0.48% stake. With a 1.40% stake in NUTX, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 9,268,251 shares are owned by the mutual fund manager. The Vanguard Extended Market Index Fu, which owns about 0.41% of NUTX stock, is the second-largest Mutual Fund holder. It holds 2,714,319 shares valued at 0.56 million. Fidelity Extended Market Index Fu holds 0.26% of the stake in NUTX, owning 1,727,238 shares worth 0.36 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NUTX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With NUTX analysts setting a high price target of $2.25 and a low target of $1.50, the average target price over the next 12 months is $1.88. Based on these targets, NUTX could surge 922.73% to reach the target high and rise by 581.82% to reach the target low. Reaching the average price target will result in a growth of 754.55% from current levels.

Summary of Insider Activity:

Insiders traded NUTX stock several times over the past three months with 4 Buys and 1 Sells. In these transactions, 1,000,000 shares were bought while 141,000 shares were sold. The number of buy transactions has increased to 17 while that of sell transactions has risen to 3 over the past year. The total number of shares bought during that period was 2,238,007 while 310,378 shares were sold.